Skip to content

Trilogy® Longevity® 00-6334-050-28 (UDI 00889024668881)Recalls & reported problems

Zimmer, Inc. · Class 2 · Implant

All models of Trilogy Longevity (29)

Data updated Oct 18, 2026 from official FDA records · Editorial policy

Adverse event reports
2
Deaths reported
0
Injuries reported
2
Recalls naming it
0

Summary

The FDA's MAUDE database contains 2 adverse event reports that list this exact device (DI 00889024668881), received between Sep 16, 2025 and Feb 5, 2026 — classified as 2 injuries.

The most frequently reported specific device problem is “Device Dislodged or Dislocated” (2 reports).

1 other recall cover devices cleared under the same FDA submission (K071718, K972774); they may or may not involve this specific model.

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.

Reports received per month

Nov 2023: 0 reportsDec 2023: 0 reportsJan 2024: 0 reportsFeb 2024: 0 reportsMar 2024: 0 reportsApr 2024: 0 reportsMay 2024: 0 reportsJun 2024: 0 reportsJul 2024: 0 reportsAug 2024: 0 reportsSep 2024: 0 reportsOct 2024: 0 reportsNov 2024: 0 reportsDec 2024: 0 reportsJan 2025: 0 reportsFeb 2025: 0 reportsMar 2025: 0 reportsApr 2025: 0 reportsMay 2025: 0 reportsJun 2025: 0 reportsJul 2025: 0 reportsAug 2025: 0 reportsSep 2025: 1 reportsOct 2025: 0 reportsNov 2025: 0 reportsDec 2025: 0 reportsJan 2026: 0 reportsFeb 2026: 1 reportsMar 2026: 0 reportsApr 2026: 0 reportsMay 2026: 0 reportsJun 2026: 0 reportsJul 2026: 0 reportsAug 2026: 0 reportsSep 2026: 0 reportsOct 2026: 0 reports2024202520261
Last 36 months. The most recent month may be incomplete.

Most reported problems

Device problems

  • Device Dislodged or Dislocated2
  • Off-Label Use1

Patient problems

  • Joint Dislocation2
  • Bone Fracture(s)1
  • Osteolysis1

Recent adverse event reports

The 2 most recent of 2 reports, in the reporter's own words as published by the FDA.

  • InjuryFeb 5, 2026Device Dislodged or Dislocated

    IT WAS REPORTED THAT THE PATIENT EXPERIENCED A CLOSED REDUCTION AND IS PENDING A LEFT HIP REVISION WITH A TRIFLANGE DUE TO DISLOCATION, OSTEOLYSIS, AND NON-DISPLACED SUPERIOR AND INFERIOR PUBIC RAMI FRACTURES. THE PATIENT HAS SOME INSTABILITY AND THE LOCKING MECHANISM FOR COMPONENTS APPARENTLY FAILED. ATTEMPTS HAVE BEEN MADE AND NO FURTHER INFORMATION HAS BEEN PROVIDED.

    Patient problems: Bone Fracture(s); Joint Dislocation; Osteolysis

    MAUDE report 24267988 ↗
  • InjurySep 16, 2025Off-Label Use; Device Dislodged or Dislocated; Off-Label Use; Device Dislodged or Dislocated

    NO ADDITIONAL INFORMATION AVAILABLE FOR THE REPORTED EVENT.

    Patient problems: Joint Dislocation

    MAUDE report 23061624 ↗

Recalls under the same FDA submission

These recalls involve devices cleared under K071718, K972774. One submission often covers many models, so check the product and lot details in each record.

  • Z-0386-2013 · Aug 27, 2012 · Terminated
    Trilogy II Constrained Liner The Trilogy Longevity Constrained Liner serves as the articular surface for a femoral head in total hip arthroplasty.

Other Prosthesis, hip, constrained, cemented or uncemented, metal/polymer devices

All Prosthesis, hip, constrained, cemented or uncemented, metal/polymer devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page